Synthetic biology and metabolic engineering of actinomycetes for natural product discovery
The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Actinomycetes are one of the most valuable sources of natural products with industrial and medicinal importance. After more than half a century of exploitation, it has become increasingly challenging to find novel natural products with useful properties as the same known compounds are often repeatedly re-discovered when using traditional approaches. Modern genome mining approaches have led to the discovery of new biosynthetic gene clusters, thus indicating that actinomycetes still harbor a huge unexploited potential to produce novel natural products. In recent years, innovative synthetic biology and metabolic engineering tools have greatly accelerated the discovery of new natural products and the engineering of actinomycetes. In the first part of this review, we outline the successful application of metabolic engineering to optimize natural product production, focusing on the use of multi-omics data, genome-scale metabolic models, rational approaches to balance precursor pools, and the engineering of regulatory genes and regulatory elements. In the second part, we summarize the recent advances of synthetic biology for actinomycetal metabolic engineering including cluster assembly, cloning and expression, CRISPR/Cas9 technologies, and chassis strain development for natural product overproduction and discovery. Finally, we describe new advances in reprogramming biosynthetic pathways through polyketide synthase and non-ribosomal peptide synthetase engineering. These new developments are expected to revitalize discovery and development of new natural products with medicinal and other industrial applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 1×
“In the simplified system of the native CRISPR, the crRNA and the tracrRNA are fused into a single synthetic guide RNA (sgRNA) (Mali et al., 2013).”
BackgroundCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 20×
“system for defense against exogenous DNA or RNA (Barrangou et al., 2007).”
BackgroundInfluentialPractical streptomyces genetics
Kieser, T. (2000) · Medical Entomology and Zoology · Cited by 3,923
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Natural products (NP) are bioactive molecules that are used for many different purposes such as herbicides, chemotherapeutics, immunosuppressants, and antibiotics (Berdy, 2005; Berdy, 2012; Hwang et al., 2014).”
BackgroundCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · cited 1×
“Once the complex binds this specific target sequence, the Cas9 nuclease activity is triggered (Nishimasu et al., 2014).”
BackgroundDiversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423
A new logic for DNA engineering using recombination in Escherichia coli
Zhang, Y., Buchholz, F., Muyrers, J. P. P., & Stewart, A. F. (1998) · Nature Genetics · doi:10.1038/2417 · Cited by 1,222 · cited 6×
“One of the first applications of the RecET-mediated LLHR method was used to clone BGCs from Photorhabdus luminescens and express them in E. coli (Fu et al., 2012; Yin et al., 2015).”
BackgroundInfluentialThoughts and facts about antibiotics: Where we are now and where we are heading
Bérdy, J. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.27 · Cited by 1,165 · cited 2×
“Natural products (NP) are bioactive molecules that are used for many different purposes such as herbicides, chemotherapeutics, immunosuppressants, and antibiotics (Berdy, 2005; Berdy, 2012; Hwang et al., 2014).”
BackgroundantiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification
Blin, K., Wolf, T., Chevrette, M. G., Lu, X., Schwalen, C. J., Kautsar, S. A., Suarez Duran, H. G., de los Santos, E. L. C., Kim, H. U., Nave, M., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx319 · Cited by 1,158 · cited 2×
“…whole genome sequences can now be easily and cheaply obtained, genome mining for secondary metabolite biosynthetic gene clusters (BGCs) has become a routine method of NP discovery in actinomycetes (Ziemert et al., 2016) complementing the classical chemistry-driven screening (Blin et al., 2017).”
BackgroundMethodSelf-citationNonribosomal Peptide Synthesis—Principles and Prospects
Süssmuth, R. D., & Mainz, A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609079 · Cited by 958
Metadata
- Authors
- Palazzotto, E., Tong, Y., Lee, S. Y., & Weber, T.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 37
- Issue
- 6
- Pages
- 107366
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2922422116
- Cited by
- 169
- References
- 187
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synthetic biology and metabolic engineering of actinomycetes for natural product discovery. https://app.cochat.ai/papers/10.1016/j.biotechadv.2019.03.005
- The paper
- Palazzotto, E., Tong, Y., Lee, S. Y., & Weber, T. (2019). Synthetic biology and metabolic engineering of actinomycetes for natural product discovery. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2019.03.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.